Infection of mice with a human influenza A/H3N2 virus induces protective immunity against lethal infection with influenza A/H5N1 virus.
about
Balancing Immune Protection and Immune Pathology by CD8(+) T-Cell Responses to Influenza InfectionDeveloping Universal Influenza Vaccines: Hitting the Nail, Not Just on the HeadTowards a universal influenza vaccine: volunteer virus challenge studies in quarantine to speed the development and subsequent licensingAirborne transmission of influenza A/H5N1 virus between ferretsCross-protective immunity against influenza A/H1N1 virus challenge in mice immunized with recombinant vaccine expressing HA gene of influenza A/H5N1 virus.Human cytotoxic T lymphocytes directed to seasonal influenza A viruses cross-react with the newly emerging H7N9 virusH1N1, but not H3N2, influenza A virus infection protects ferrets from H5N1 encephalitis.Assessment of influenza virus hemagglutinin stalk-based immunity in ferrets.Humans and ferrets with prior H1N1 influenza virus infections do not exhibit evidence of original antigenic sin after infection or vaccination with the 2009 pandemic H1N1 influenza virusDiverse heterologous primary infections radically alter immunodominance hierarchies and clinical outcomes following H7N9 influenza challenge in micePossible Impact of Yearly Childhood Vaccination With Trivalent Inactivated Influenza Vaccine (TIV) on the Immune Response to the Pandemic Strain H1N1.Long-Lasting Cross-Protection Against Influenza A by Neuraminidase and M2e-based immunization strategiesPrior infection with classical swine H1N1 influenza viruses is associated with protective immunity to the 2009 pandemic H1N1 virus.Increased Protein Degradation Improves Influenza Virus Nucleoprotein-Specific CD8+ T Cell Activation In Vitro but Not in C57BL/6 MiceA single dose of DNA vaccine based on conserved H5N1 subtype proteins provides protection against lethal H5N1 challenge in mice pre-exposed to H1N1 influenza virus.Biopolymer encapsulated live influenza virus as a universal CD8+ T cell vaccine against influenza virus.Cross-protective immunity to influenza A viruses.Development of adenoviral vector-based mucosal vaccine against influenza.Vaccination against seasonal influenza A/H3N2 virus reduces the induction of heterosubtypic immunity against influenza A/H5N1 virus infection in ferretsHeterosubtypic antibody response elicited with seasonal influenza vaccine correlates partial protection against highly pathogenic H5N1 virus.Characterization of the human CD8⁺ T cell response following infection with 2009 pandemic influenza H1N1 virus.Targets for the induction of protective immunity against influenza a viruses.Induction of virus-specific cytotoxic T lymphocytes as a basis for the development of broadly protective influenza vaccinesNatural and long-lasting cellular immune responses against influenza in the M2e-immune host.Building and optimizing a virus-specific T cell receptor library for targeted immunotherapy in viral infections.Antibody responses and cross protection against lethal influenza A viruses differ between the sexes in C57BL/6 mice.Computational Characterization of Transient Strain-Transcending Immunity against Influenza A.Increased risk of noninfluenza respiratory virus infections associated with receipt of inactivated influenza vaccineInfluenza B virus-specific CD8+ T-lymphocytes strongly cross-react with viruses of the opposing influenza B lineageInfection of the upper respiratory tract with seasonal influenza A(H3N2) virus induces protective immunity in ferrets against infection with A(H1N1)pdm09 virus after intranasal, but not intratracheal, inoculation.Evasion of influenza A viruses from innate and adaptive immune responses.Predicting the pathogenesis of influenza from genomic response: a step toward early diagnosis.Does exposure to poultry and wild fowl confer immunity to H5N1?Mathematical Model Reveals the Role of Memory CD8 T Cell Populations in Recall Responses to Influenza.Heat-killed Lactobacillus casei confers broad protection against influenza A virus primary infection and develops heterosubtypic immunity against future secondary infection.Extensive T cell cross-reactivity between diverse seasonal influenza strains in the ferret model.Harnessing the Power of T Cells: The Promising Hope for a Universal Influenza Vaccine.Intermediate levels of vaccination coverage may minimize seasonal influenza outbreaks.Cross-Protective Immune Responses Induced by Sequential Influenza Virus Infection and by Sequential Vaccination With Inactivated Influenza Vaccines
P2860
Q26767517-01E4A195-5823-4EDD-B3A3-99039BE1CF7DQ26783897-2B1B6902-8011-42FA-ABB4-135B021858B4Q27003874-44E8048F-BBF0-4BF7-B6F3-47001B14841FQ29619970-A69D6231-5921-4281-905F-2A21BDB67F65Q30353786-23CED3F5-847D-4714-B659-B23757E8BF0BQ30355817-BB59192B-DA35-4B50-B854-D951CFC379F1Q30357273-0E21B169-7BE1-4A13-9D2D-E7F3FF322437Q30357665-6B13EEA0-5718-4D39-8EDB-1CDE12F8C9D9Q30360439-F6D308FB-9B13-4816-8524-CF985B57BA0EQ30371622-D609B0DB-C175-4E33-8516-CC2679D19360Q30376475-DC863CD2-AED7-4AF6-95E1-2E55ED5CFDE7Q30386823-7E607065-7025-454F-A1A6-BE028EE9501BQ30388369-C26995E2-2AF5-4F41-BF68-4F67ACC52B35Q30392456-975351F9-653A-43FE-9C0E-A1D9F99F7E53Q30392828-C8461956-F14B-43CB-9890-1D7806EA97B8Q30395580-9BF21711-2AD2-4BC4-B278-267A76912BC8Q30396399-6B963407-7C60-4A15-8DCF-A8ACF6D16E82Q30396642-E9DE175E-9940-4A37-A57D-418A96DF099AQ30398516-50F0C4B4-D222-4FFF-8F5B-0A9EB0DEBEB0Q30401524-6A3B85A2-5A1B-4E35-9975-E55248D5A2F7Q30407075-70EAE6FA-B5F8-476D-BECA-898DC15D2B48Q30408100-98D93C04-657B-4A17-9FE3-41661B1D0395Q30408295-9A180702-FF0E-49A4-B89C-8AB64F69D65BQ30419297-2AFEBC8B-B761-4C74-A68E-B9DACFC55934Q35102451-54A41B60-FBFA-4DA2-90D0-C38E7FE731E4Q35503099-9A9F0B1A-D827-4BFD-8CDF-CCB96F44CC0DQ35620267-A7EB9DE3-C401-4005-82D2-B3B0DFD6C05AQ36115609-847D153B-6D99-42E2-B21B-433826538513Q36376605-7012888B-CC70-422E-A9A3-40BABA910855Q36760233-400E1C20-84BE-4C62-87B4-B35BAADB403AQ38061423-92D66C36-FFBB-4BFF-9845-D06D01AA6514Q39827174-E89BF5CF-AB43-437B-ADA3-2DBD6F970C43Q40143746-2B1C070F-2E24-45A4-BE30-6D9E0143C189Q40652515-0E460FFE-745E-4C3C-90A4-A7A222B33877Q47132462-DA76ACB7-591B-46A6-95BD-CB3FBA09F1E8Q52718693-16DCFEFC-D924-4591-812E-C97B0AA4D73BQ54247364-121AB8B0-95A7-4F2D-BF63-4B1BE4997BEBQ55499955-B812209A-FDF4-447A-B5B6-B5602B2A6DCFQ57816687-35F2C0F5-741E-46C5-B1B0-668500DEA3DB
P2860
Infection of mice with a human influenza A/H3N2 virus induces protective immunity against lethal infection with influenza A/H5N1 virus.
description
2009 nî lūn-bûn
@nan
2009 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Infection of mice with a human ...... n with influenza A/H5N1 virus.
@ast
Infection of mice with a human ...... n with influenza A/H5N1 virus.
@en
type
label
Infection of mice with a human ...... n with influenza A/H5N1 virus.
@ast
Infection of mice with a human ...... n with influenza A/H5N1 virus.
@en
prefLabel
Infection of mice with a human ...... n with influenza A/H5N1 virus.
@ast
Infection of mice with a human ...... n with influenza A/H5N1 virus.
@en
P2093
P1433
P1476
Infection of mice with a human ...... n with influenza A/H5N1 virus.
@en
P2093
A D M E Osterhaus
G F Rimmelzwaan
G de Mutsert
G van Amerongen
J H C M Kreijtz
J M A van den Brand
R A M Fouchier
P304
P356
10.1016/J.VACCINE.2009.05.079
P407
P577
2009-06-16T00:00:00Z